| Long-term safety ofin uteroexposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study M Chaparro, A Verreth, T Lobaton, E Gravito-Soares, M Julsgaard, ... Official journal of the American College of Gastroenterology| ACG 113 (3 …, 2018 | 176 | 2018 |
| Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain) I Rodríguez-Lago, PR de la Piscina, A Elorza, O Merino, JO de Zárate, ... Gastroenterology 159 (2), 781-783, 2020 | 89 | 2020 |
| Real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry M Iborra, B Beltrán, A Fernández‐Clotet, A Gutiérrez, B Antolín, ... Alimentary pharmacology & therapeutics 50 (3), 278-288, 2019 | 70 | 2019 |
| Real‐world long‐term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry M Iborra, B Beltrán, A Fernández‐Clotet, E Iglesias‐Flores, P Navarro, ... Alimentary Pharmacology & Therapeutics 52 (6), 1017-1030, 2020 | 55 | 2020 |
| Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: a multicentre retrospective cohort study I Guerra, L Bujanda, J Castro, O Merino, J Tosca, B Camps, A Gutiérrez, ... Journal of Crohn's and Colitis 13 (12), 1492-1500, 2019 | 49 | 2019 |
| Effectiveness and safety of the sequential use of a second and third anti-TNF agent in patients with inflammatory bowel disease: results from the Eneida Registry MJ Casanova, M Chaparro, M Mínguez, E Ricart, C Taxonera, ... Inflammatory Bowel Diseases 26 (4), 606-616, 2020 | 44 | 2020 |
| Results of the Seventh Scientific Workshop of ECCO: precision medicine in IBD—prediction and prevention of inflammatory bowel disease J Torres, J Halfvarson, I Rodríguez-Lago, CRH Hedin, T Jess, M Dubinsky, ... Journal of Crohn's and Colitis 15 (9), 1443-1454, 2021 | 41 | 2021 |
| Ramírez de la Piscina P, Elorza A, Merino O, Ortiz de Zárate J, Cabriada JL. Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 … I Rodríguez-Lago Gastroenterology 159 (2), 781-783, 2020 | 39 | 2020 |
| Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: nationwide multicenter study of the GETECCU ENEIDA Registry I Ordás, E Domènech, M Mañosa, V García-Sánchez, E Iglesias-Flores, ... Official journal of the American College of Gastroenterology| ACG 113 (7 …, 2018 | 39 | 2018 |
| Characteristics and progression of preclinical inflammatory bowel disease I Rodríguez-Lago, O Merino, I Azagra, A Maiz, E Zapata, R Higuera, ... Clinical Gastroenterology and Hepatology 16 (9), 1459-1466, 2018 | 31 | 2018 |
| Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry X Andújar, C Loras, B González, M Socarras, V Sanchiz, M Boscà, ... Surgical Endoscopy 34, 1112-1122, 2020 | 30 | 2020 |
| Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease I Rodríguez-Lago, JD Hoyo, A Pérez-Girbés, A Garrido-Marín, ... United European Gastroenterology Journal 8 (9), 1056-1066, 2020 | 27 | 2020 |
| The role of immunomodulators and biologics in the medical management of stricturing Crohn’s disease I Rodríguez-Lago, JP Gisbert Journal of Crohn's and Colitis 14 (4), 557-566, 2020 | 25 | 2020 |
| Long-term follow-up study of gastroduodenal lesions after radioembolization of hepatic tumors I Rodríguez-Lago, C Carretero, M Herráiz, JC Subtil, M Betés, ... World Journal of Gastroenterology: WJG 19 (19), 2935, 2013 | 25 | 2013 |
| How to optimize treatment with ustekinumab in inflammatory bowel disease: lessons learned from clinical trials and real-world data A Gutiérrez, I Rodríguez-Lago Frontiers in Medicine 8, 640813, 2021 | 23 | 2021 |
| Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection A Zabaleta, D D'avola, I Echeverria, D Llopiz, L Silva, L Villanueva, ... Molecular therapy Methods & clinical development 2, 2015 | 23 | 2015 |
| Granulocyte–monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis I Rodríguez–Lago, L Sempere, A Gutiérrez, A Núñez, E Leo Carnerero, ... Scandinavian Journal of Gastroenterology 54 (4), 459-464, 2019 | 21 | 2019 |
| COVID‐19 in gastroenterology: where are we now? Current evidence on the impact of COVID‐19 in gastroenterology F Magro, A Nuzzo, C Abreu, D Libânio, I Rodriguez‐Lago, K Pawlak, ... UEG Journal 9 (7), 750-765, 2021 | 19 | 2021 |
| Reviewing the therapeutic role of budesonide in Crohn's disease A López-Sanromán, J Clofent, E Garcia-Planella, L Menchén, P Nos, ... Gastroenterología Y Hepatología (English Edition) 41 (7), 458-471, 2018 | 19 | 2018 |
| Re-induction with intravenous ustekinumab in patients with Crohn’s disease and a loss of response to this therapy F Bermejo, L Jiménez, A Algaba, M Vela, G Bastida, O Merino, ... Inflammatory Bowel Diseases 28 (1), 41-47, 2022 | 16 | 2022 |
